Which options may ease a sore hip?

What can you try at home?

Ease back on the movement that starts the ache, but keep moving when you can. Short, level walks may feel better than hills, deep bends or long periods of standing.

A cane held opposite the sore hip can take off some strain. Ask a doctor or druggist whether common pain medicines are safe for your heart, kidneys and stomach.

Sleep on the other side if pressure on the outer hip brings soreness. A pillow between the knees may also make that position easier.

What care may come before surgery?

A doctor may suggest guided strength work, medicine or a procedure done in the office. The exam, X-rays and health risks help narrow the choices for tasks soreness has taken away.

PRP stands for platelet-rich plasma, a treatment made from a spun sample of your blood. Spinning gathers more platelets, the small blood pieces used in this clinic care.

The office places that blood portion in the sore area. This is called a regenerative treatment because it uses your body's prepared blood during care.

Ask whether the sore spot will be located by touch, an X-ray or another scan. Also ask what the first few days after the procedure usually involve.

Pick one hard daily task, such as rising from a chair. At the next visit, report whether that task has grown easier, stayed the same or worsened.

When does hip surgery make sense?

A doctor may raise surgery when pain at rest and limits on walking stay severe. Major joint damage on an X-ray can support surgery, but the X-ray isn't enough alone.

Sleep, stairs and ordinary chores tell the doctor how much the hip limits daily life. Ask how much each option may improve the tasks that now hurt.

Sources

1. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-efficacy and self-management programmes, tai chi, cane use and oral NSAIDs across hand, hip and knee OA - but its strong recommendations for topical NSAIDs and for intra-articular glucocorticoid injection are specific to the KNEE, not the hip.

   Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41142.

2. OARSI 2019 designates arthritis education plus structured land-based exercise as CORE treatments for hip OA, and explicitly states that intra-articular corticosteroids, intra-articular hyaluronic acid and aquatic exercise - Level 1B/2 treatments for KNEE OA - were NOT recommended for individuals with hip or polyarticular OA. Oral and transdermal opioids are strongly not recommended (Level 5).

   Bannuru RR, et al. — OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.. Osteoarthritis and Cartilage, 2019. DOI: 10.1016/j.joca.2019.06.011.

3. The 2026 Cochrane update of exercise for hip osteoarthritis (18 trials, 1368 participants) found that against attention control or placebo, exercise may have little to no effect on pain (MD -6.31 points on 0-100, 95% CI -12.98 to 0.35, low certainty) and may improve physical function only slightly; against no treatment or usual care it probably reduces pain slightly (MD -7.19, 95% CI -10.70 to -3.68, moderate certainty) but the review states these improvements are unlikely to be clinically meaningful. This is a weaker result than the equivalent knee evidence and it must not be overstated.

   Hall M, et al. — Exercise for osteoarthritis of the hip.. Cochrane Database of Systematic Reviews, 2026. DOI: 10.1002/14651858.CD007912.pub3.

4. The AAOS evidence-based clinical practice guideline on Management of Osteoarthritis of the Hip states verbatim: STRONG evidence supports intra-articular corticosteroids to improve function and reduce pain in the SHORT TERM; STRONG evidence does NOT support intra-articular hyaluronic acid, because it does not perform better than placebo for function, stiffness and pain; STRONG evidence supports physical therapy for mild to moderate symptoms; STRONG evidence supports NSAIDs for short-term pain and function; and MODERATE evidence does not support glucosamine sulfate.

   American Academy of Orthopaedic Surgeons — Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline.. AAOS, 2017.

5. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.

6. A network meta-analysis restricted to LARGE intra-articular trials (57 RCTs, 22,795 participants, >=100 patients per group) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. Excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CI -0.19 to 0.11) with higher odds of dropouts due to adverse events (OR 2.01) and serious adverse events (OR 1.86) than placebo. Effects of 16 of 18 interventions were smaller than the MID.

   Pereira TV, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.. Osteoarthritis and Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.

7. In a three-arm randomized trial of 204 people with MRI-confirmed gluteal tendinopathy, an eight-week physiotherapist-led education and exercise programme produced success on global rating of change in 51/66 participants at 8 weeks versus 38/65 for a single corticosteroid injection and 20/68 for wait-and-see. Education plus exercise beat the injection at 8 weeks (risk difference 19.9%) and still beat it at 52 weeks (20.4%).

   Mellor R, et al. — Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial.. BMJ, 2018. DOI: 10.1136/bmj.k1662.

8. In a double-blind RCT of 80 patients with chronic gluteal tendinopathy, a single ultrasound-guided intratendinous PRP injection produced a significantly better modified Harris Hip Score at 12 weeks than a single corticosteroid injection (74.05 vs 67.13, P=.048), with 82% versus 56.7% reaching the minimal clinically important difference.

   Fitzpatrick J, et al. — The Effectiveness of Platelet-Rich Plasma Injections in Gluteal Tendinopathy: A Randomized, Double-Blind Controlled Trial Comparing a Single Platelet-Rich Plasma Injection With a Single Corticosteroid Injection.. American Journal of Sports Medicine, 2018. DOI: 10.1177/0363546517745525.

9. At two-year follow-up of the same 80-patient trial, the leukocyte-rich PRP group continued to improve (mHHS 53.77 at baseline to 82.59 at 104 weeks, P<.0001) while the corticosteroid group peaked at about 6 weeks and had lost the benefit by 24 weeks; 27 corticosteroid patients were deemed treatment failures at 16-24 weeks and crossed over.

   Fitzpatrick J, et al. — Leucocyte-Rich Platelet-Rich Plasma Treatment of Gluteus Medius and Minimus Tendinopathy: A Double-Blind Randomized Controlled Trial With 2-Year Follow-up.. American Journal of Sports Medicine, 2019. DOI: 10.1177/0363546519826969.